首页 › 基金 › Fortis Group Advisors, LLC › PPH

Fortis Group Advisors, LLC 对 PPH 的持仓历史

VANECK PHARMACEUTICAL ETF

Fortis Group Advisors, LLC 在 Q3 2026 的 13F 申报中披露持有 PPH(VANECK PHARMACEUTICAL ETF)31,593 股,市值约 US$3.8M,约占其申报组合的 0.60%,在其申报持仓中市值排名第 49 位。 Fortis Group Advisors, LLC 于 Q3 2026 首次申报该持仓。

最新持仓 (Q3 2026)31.59K 股
申报持仓市值$3.77M
组合权重0.60%
首次申报Q3 2026
最近变动新进
更新于2026-11-13

最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR

Fortis Group Advisors, LLC 对 PPH 的持仓演变

Fortis Group Advisors, LLC 于 Q3 2026 首次披露 PPH 持仓:31,593 股(约 US$3.8M)。

逐季持仓明细

季度股数金额变化
Q3 2026 31.59K $3.77M 新进

关于 PPH 与 13F 数据

PPH(VANECK PHARMACEUTICAL ETF)的行业分类暂缺。我们追踪的基金中还有 20 只申报持有 PPH,申报仓位最大的包括:J.Safra Asset Management Corp (US$35.9M), Avalon Trust Co (US$27.8M), ADAMSBROWN WEALTH CONSULTANTS LLC (US$11.1M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 PPH 的基金

查看 PPH 的全部基金持有人 →

常见问题

How long has Fortis Group Advisors, LLC held PPH?

Fortis Group Advisors, LLC has disclosed PPH holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Fortis Group Advisors, LLC's current position in PPH?

As of Q3 2026, Fortis Group Advisors, LLC holds 31.59K shares of PPH (VANECK PHARMACEUTICAL ETF), valued at $3.77M, representing 0.60% of its reported portfolio and ranking #49.

Has Fortis Group Advisors, LLC been buying or selling PPH?

In the latest 13F filing (Q3 2026), Fortis Group Advisors, LLC newly opened its position in PPH.

Which other funds hold PPH?

Other major institutional holders of PPH include J.Safra Asset Management Corp, Avalon Trust Co, ADAMSBROWN WEALTH CONSULTANTS LLC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.